Literature DB >> 23891629

The impact of uterine leiomyomas: a national survey of affected women.

Bijan J Borah1, Wanda K Nicholson, Linda Bradley, Elizabeth A Stewart.   

Abstract

OBJECTIVE: We sought to characterize the impact of uterine leiomyomas (fibroids) in a racially diverse sample of women in the United States. STUDY
DESIGN: A total of 968 women (573 white, 268 African American, 127 other races) aged 29-59 years with self-reported symptomatic uterine leiomyomas participated in a national survey. We assessed diagnosis, information seeking, attitudes about fertility, impact on work, and treatment preferences. Frequencies and percentages were summarized. The χ(2) test was used to compare age groups.
RESULTS: Women waited an average of 3.6 years before seeking treatment for leiomyomas, and 41% saw ≥2 health care providers for diagnosis. Almost a third of employed respondents (28%) reported missing work due to leiomyoma symptoms, and 24% believed that their symptoms prevented them from reaching their career potential. Women expressed desire for treatments that do not involve invasive surgery (79%), preserve the uterus (51%), and preserve fertility (43% of women aged <40 years).
CONCLUSION: Uterine leiomyomas cause significant morbidity. When considering treatment, women are most concerned about surgical options, especially women aged <40 years who want to preserve fertility.
Copyright © 2013 Mosby, Inc. All rights reserved.

Entities:  

Keywords:  hysterectomy; leiomyoma; quality of life; symptoms; uterine fibroids

Mesh:

Year:  2013        PMID: 23891629      PMCID: PMC4167669          DOI: 10.1016/j.ajog.2013.07.017

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  23 in total

1.  Shared medical decision making. A new tool for preventive medicine.

Authors:  Robert M Kaplan
Journal:  Am J Prev Med       Date:  2004-01       Impact factor: 5.043

2.  A modified poisson regression approach to prospective studies with binary data.

Authors:  Guangyong Zou
Journal:  Am J Epidemiol       Date:  2004-04-01       Impact factor: 4.897

Review 3.  Uterine fibroids: the elephant in the room.

Authors:  Cheryl Lyn Walker; Elizabeth A Stewart
Journal:  Science       Date:  2005-06-10       Impact factor: 47.728

4.  Health care resource use for uterine fibroid tumors in the United States.

Authors:  Michael Flynn; Margaret Jamison; Santanu Datta; Evan Myers
Journal:  Am J Obstet Gynecol       Date:  2006-05-24       Impact factor: 8.661

Review 5.  Indications for hysterectomy.

Authors:  K J Carlson; D H Nichols; I Schiff
Journal:  N Engl J Med       Date:  1993-03-25       Impact factor: 91.245

6.  Age-specific incidence rates for self-reported uterine leiomyomata in the Black Women's Health Study.

Authors:  Lauren A Wise; Julie R Palmer; Elizabeth A Stewart; Lynn Rosenberg
Journal:  Obstet Gynecol       Date:  2005-03       Impact factor: 7.661

7.  The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata.

Authors:  James B Spies; Karin Coyne; Noureddine Guaou Guaou; Deneane Boyle; Kerry Skyrnarz-Murphy; Sheila M Gonzalves
Journal:  Obstet Gynecol       Date:  2002-02       Impact factor: 7.661

8.  Variation in the incidence of uterine leiomyoma among premenopausal women by age and race.

Authors:  L M Marshall; D Spiegelman; R L Barbieri; M B Goldman; J E Manson; G A Colditz; W C Willett; D J Hunter
Journal:  Obstet Gynecol       Date:  1997-12       Impact factor: 7.661

9.  Reproductive factors, hormonal contraception, and risk of uterine leiomyomata in African-American women: a prospective study.

Authors:  Lauren A Wise; Julie R Palmer; Bernard L Harlow; Donna Spiegelman; Elizabeth A Stewart; Lucile L Adams-Campbell; Lynn Rosenberg
Journal:  Am J Epidemiol       Date:  2004-01-15       Impact factor: 4.897

10.  Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women.

Authors:  Anne Zimmermann; David Bernuit; Christoph Gerlinger; Matthias Schaefers; Katharina Geppert
Journal:  BMC Womens Health       Date:  2012-03-26       Impact factor: 2.809

View more
  61 in total

Review 1.  High-Intensity Focused Ultrasound: Current Status for Image-Guided Therapy.

Authors:  Alexander Copelan; Jason Hartman; Monzer Chehab; Aradhana M Venkatesan
Journal:  Semin Intervent Radiol       Date:  2015-12       Impact factor: 1.513

2.  Vitamin D and uterine leiomyoma among a sample of US women: Findings from NHANES, 2001-2006.

Authors:  Susanna D Mitro; Ami R Zota
Journal:  Reprod Toxicol       Date:  2015-06-03       Impact factor: 3.143

3.  Burden, Prevalence, and Treatment of Uterine Fibroids: A Survey of U.S. Women.

Authors:  Erica E Marsh; Ayman Al-Hendy; Dale Kappus; Alex Galitsky; Elizabeth A Stewart; Majid Kerolous
Journal:  J Womens Health (Larchmt)       Date:  2018-09-19       Impact factor: 2.681

4.  Ulipristal Acetate for Treatment of Symptomatic Uterine Leiomyomas: A Randomized Controlled Trial.

Authors:  James A Simon; William Catherino; James H Segars; Rick E Blakesley; Anna Chan; Vilma Sniukiene; Ayman Al-Hendy
Journal:  Obstet Gynecol       Date:  2018-03       Impact factor: 7.661

Review 5.  Focused ultrasound: tumour ablation and its potential to enhance immunological therapy to cancer.

Authors:  Giovanni Mauri; Luca Nicosia; Zhen Xu; Salvatore Di Pietro; Lorenzo Monfardini; Guido Bonomo; Gianluca Maria Varano; Francesco Prada; Paolo Della Vigna; Franco Orsi
Journal:  Br J Radiol       Date:  2018-01-17       Impact factor: 3.039

6.  Optimizing research in symptomatic uterine fibroids with development of a computable phenotype for use with electronic health records.

Authors:  Sarah R Hoffman; Anissa I Vines; Jacqueline R Halladay; Emily Pfaff; Lauren Schiff; Daniel Westreich; Aditi Sundaresan; La-Shell Johnson; Wanda K Nicholson
Journal:  Am J Obstet Gynecol       Date:  2018-02-09       Impact factor: 8.661

Review 7.  Magnetic Resonance-Guided High-Intensity Focused Ultrasound (MRgHIFU) Treatment of Symptomatic Uterine Fibroids: An Evidence-Based Analysis.

Authors:  G Pron
Journal:  Ont Health Technol Assess Ser       Date:  2015-03-01

8.  Integrated interventions for improving negative emotions and stress reactions of young women receiving total hysterectomy.

Authors:  Fen Wang; Chun-Bo Li; Shenghua Li; Quan Li
Journal:  Int J Clin Exp Med       Date:  2014-01-15

9.  An Altered Perception of Normal: Understanding Causes for Treatment Delay in Women with Symptomatic Uterine Fibroids.

Authors:  Marissa S Ghant; Katherine S Sengoba; Robert Vogelzang; Angela K Lawson; Erica E Marsh
Journal:  J Womens Health (Larchmt)       Date:  2016-05-19       Impact factor: 2.681

Review 10.  Epidemiology of Uterine Fibroids: From Menarche to Menopause.

Authors:  Lauren A Wise; Shannon K Laughlin-Tommaso
Journal:  Clin Obstet Gynecol       Date:  2016-03       Impact factor: 2.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.